Intraoral Hypothermia Device for Preserving Taste During Radiation
Part of paid clinical trials in Detroit, Michigan.
- Sponsor
- Henry Ford Health System
- Study ID
- NCT06579248
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Head and Neck Cancer
- Radiation Therapy
- Taste Dysfunction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Intraoral Device — DEVICEDevice that circulates cooled water through the oral cavity.
Study Details
Radiation therapy to the head and neck region is known to cause taste dysfunction. Preliminary studies showed that cooling normal structures may lower damage caused by radiation. The purpose of this research study is to see if it is feasible to use an intraoral cooling device during radiation treatments to preserve or lower the decline of taste function.
Key Dates
- Start date
- Nov 12, 2024
- Status verified
- Jan 2026
- Primary completion
- Aug 30, 2026
- Completion
- Aug 30, 2026
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Intraoral Hypothermia DeviceAn intraoral hypothermia device will be used to cool the oral cavity while subject's receive radiation therapy.
Primary Outcome Measure
Change in Dysgeusia [ Time Frame: 6 months after RT completion ]
Central Contacts
- Marissa Gilbert, BSBME313-556-8422
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Henry Ford Health System | Detroit | Michigan | 48202-2689 | Farzan Siddiqui, MD PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Detroit, MI
By condition
By research site
Related Studies
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCTRecruiting · Medical University of South Carolina · Detroit, Michigan
- A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsPHASE1 · Recruiting · Aktis Oncology, Inc. · Duarte, California
- A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsPHASE1 · Recruiting · ALX Oncology Inc. · Tampa, Florida